Engineers Gate Manager’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.6M | Buy |
32,630
+7,238
| +29% | +$2.36M | 0.13% | 209 |
|
2025
Q1 | $6.86M | Sell |
25,392
-8,505
| -25% | -$2.3M | 0.12% | 242 |
|
2024
Q4 | $7.98M | Buy |
33,897
+22,034
| +186% | +$5.18M | 0.14% | 208 |
|
2024
Q3 | $3.26M | Buy |
11,863
+4,789
| +68% | +$1.32M | 0.06% | 429 |
|
2024
Q2 | $1.72M | Sell |
7,074
-17,649
| -71% | -$4.29M | 0.04% | 625 |
|
2024
Q1 | $3.69M | Buy |
24,723
+7,292
| +42% | +$1.09M | 0.1% | 277 |
|
2023
Q4 | $3.34M | Buy |
+17,431
| New | +$3.34M | 0.1% | 289 |
|
2023
Q3 | – | Sell |
-5,286
| Closed | -$1M | – | 1769 |
|
2023
Q2 | $1M | Sell |
5,286
-909
| -15% | -$173K | 0.04% | 689 |
|
2023
Q1 | $1.24M | Buy |
+6,195
| New | +$1.24M | 0.05% | 504 |
|
2022
Q4 | – | Sell |
-1,957
| Closed | -$392K | – | 1652 |
|
2022
Q3 | $392K | Sell |
1,957
-3,467
| -64% | -$694K | 0.02% | 958 |
|
2022
Q2 | $791K | Buy |
+5,424
| New | +$791K | 0.03% | 848 |
|
2022
Q1 | – | Sell |
-1,990
| Closed | -$337K | – | 1817 |
|
2021
Q4 | $337K | Buy |
1,990
+856
| +75% | +$145K | 0.02% | 1320 |
|
2021
Q3 | $214K | Sell |
1,134
-14,830
| -93% | -$2.8M | 0.01% | 1402 |
|
2021
Q2 | $2.71M | Buy |
15,964
+13,054
| +449% | +$2.21M | 0.17% | 114 |
|
2021
Q1 | $411K | Buy |
2,910
+420
| +17% | +$59.3K | 0.02% | 1114 |
|
2020
Q4 | $324K | Buy |
2,490
+1,090
| +78% | +$142K | 0.01% | 1252 |
|
2020
Q3 | $204K | Sell |
1,400
-2,100
| -60% | -$306K | 0.01% | 1425 |
|
2020
Q2 | $518K | Buy |
+3,500
| New | +$518K | 0.03% | 926 |
|
2020
Q1 | – | Sell |
-3,260
| Closed | -$375K | – | 1537 |
|
2019
Q4 | $375K | Buy |
+3,260
| New | +$375K | 0.02% | 1137 |
|
2015
Q4 | – | Sell |
-4,600
| Closed | -$370K | – | 637 |
|
2015
Q3 | $370K | Buy |
4,600
+2,100
| +84% | +$169K | 0.03% | 492 |
|
2015
Q2 | $300K | Buy |
+2,500
| New | +$300K | 0.03% | 795 |
|